Xenetic Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.9%.

Top 22 shareholders own 17.85% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.73%	CLS Therapeutics, Inc.	147,500	€484.9k	0%	no data
2.95%	Public Joint-Stock Company "Pharmsynthez"	44,712	€147.0k	0%	no data
1.23%	Alexey Vinogradov	18,678	€61.4k	0%	no data
0.66%	Renaissance Technologies LLC	9,950	€32.7k	-30.6%	no data
0.64%	The Vanguard Group, Inc.	9,698	€31.9k	-38.9%	no data
0.6%	Geode Capital Management, LLC	9,154	€30.1k	-0.87%	no data
0.51%	Susquehanna International Group, LLP, Asset Management Arm	7,781	€25.6k	211%	no data
0.25%	Hudson River Trading LLC, Asset Management Arm	3,747	€12.3k	-33.6%	no data
0.23%	State Street Global Advisors, Inc.	3,466	€11.4k	0%	no data
0.18%	Royal Bank of Canada Trust Company (Bahamas) Limited, Asset Management Arm	2,700	€8.9k	0.04%	no data
0.15%	Michael Maguire	2,202	€7.2k	0%	no data
0.13%	Two Sigma Securities, LLC, Asset Management Arm	2,022	€6.6k	0%	no data
0.13%	Steward Partners Investment Advisory, LLC	1,900	€6.2k	0%	no data
0.12%	Northern Trust Global Investments	1,776	€5.8k	0%	no data
0.11%	Citadel Advisors LLC	1,636	€5.4k	-49.8%	no data
0.084%	Ergoteles LLC	1,277	€4.2k	-32.2%	no data
0.075%	Tower Research Capital LLC	1,135	€3.7k	0%	no data
0.07%	Great Valley Advisor Group, Inc.	1,060	€3.5k	0%	no data
0.019%	Morgan Stanley & Co. International Plc Investment Account	295	€969.7	-50.5%	no data
0.0017%	NewSquare Capital, LLC	26	€85.3	0%	no data
0.0014%	Strategic Advisers LLC	21	€68.8	2,000%	no data
0.00066%	Wells Fargo & Company, Private Banking and Investment Banking Arm	10	€32.9	0%	no data